Results 121 to 130 of about 57,565 (259)

Urokinase Plasminogen Activator Receptor‐Associated Protein (uPARAP) as a Potential Next Generation Molecular Target for Treatment of Gastrointestinal Stromal Tumors (GIST)

International Journal of Cancer, Volume 159, Issue 3, Page 797-808, 1 August 2026.
A key component of the collagen internalization and lysosomal degradation cellular machinery, uPARAP may contribute to cancer progression. Here, the authors explored the expression of uPARAP in gastrointestinal stromal tumors using well‐annotated clinical patient samples and specimens from cell line‐ and patient‐derived xenografts.
Chao‐Chi Wang, Flavia Paternostro, Agnieszka Wozniak, Lore De Cock, Luna De Sutter, Kimberly Verbeeck, Ulla Vanleeuw, Daniël Gorgels, Che‐Jui Lee, Raf Sciot, Patrick Schöffski   +10 more
wiley   +1 more source

32th European Congress of Cytolotgy

, 2006
Malignant mesothelioma is a primary cancer of the serosal cavities, an anatomic site that is also frequently affected by metastatic disease, predominantly from primary carcinomas of the lung, breast, and ovary.
VETRANI, ANTONIO
core  

Development and Release of the Munich UICC Staging Tool (MUST): Advancing UICC Staging in Real‐World Data With Insights From Pancreatic and Stomach Cancer

International Journal of Cancer, Volume 159, Issue 3, Page 757-767, 1 August 2026.
Accurate cancer staging is essential for cancer research and treatment evaluation. However, real‐world data often include incomplete or inconsistent UICC staging classifications. The presented Munich UICC Staging Tool (MUST) automates UICC stage derivation from TNM classifications and tumor characteristics, incorporating novel real‐world data rules to ...
Brigitte Kühnel, Sophie Schneiderbauer, Sebastian Lange, Dirk Wilhelm, Helmut Friess, Marcus Feith, Ursula Ehmer, Florian Bassermann, Julian W. Holch, Stefan M. Munker, Jens Neumann, Jens Werner, Hubert J. Stein, Theres Fey, Ulrich Mansmann, Hana Algül, Karin Berger‐Thürmel, H. Carlo Maurer, Daniel Nasseh   +18 more
wiley   +1 more source

Pleural mesothelioma: management updates and nursing initiatives to improve patient care

, 2014
Rebecca H LehtoCollege of Nursing, Michigan State University, East Lansing, MI, USAAbstract: Malignant pleural mesothelioma is a relatively rare but aggressive malignancy that is primarily associated with occupational asbestos exposure.
Lehto RH
core  

A peculiar presentation of tamponade: pericardial mesothelioma

Pericardial mesothelioma (PM) is rare with only 200 cases recorded, and a post-mortem prevalence of
Wijesinghe, Wisalya, Stroebel, Andrie, Syed Ahmad, Syed Danial, Kirk, Frazer, He, Cheng   +4 more
core   +1 more source

Pleural mesothelioma in household members of asbestos-exposed workers in Friuli Venezia Giulia, Italy

, 2017
OBJECTIVES: Malignant mesothelioma is closely associated to asbestos exposure. One such exposure may occur through contact with occupationally exposed household members and their belongings.
Flavia D' Agostin, Flavia D'Agostin, Paola de Michieli, Corrado Negro, NEGRO, CORRADO, D'AGOSTIN, FLAVIA, DE MICHIELI, PAOLA   +6 more
core   +1 more source

Malignant craniopharyngiomas: Institutional experience and literature review

Brain Pathology, Volume 36, Issue 4, July 2026.
We report the second case of malignant craniopharyngioma with BAP1 and TP53 mutations. A literature review identified 44 cases of malignant craniopharyngiomas with a median overall survival of 6 months. Eighteen (41%) occurred in patients without any history of radiation, suggesting that mechanisms other than radiation have contributed to their ...
Thomas J. Auen, Isabella W. Zhang, Weiwei Zhang, Jordan M. Burr, Matthew L. Carda, James L. Wisecarver, Nicole Shonka, Jesse L. Cox, Sahara J. Cathcart, Allison Cushman‐Vokoun, Jie Chen   +10 more
wiley   +1 more source

Development of novel anti-cancer immunotherapies against Malignant Pleural Mesothelioma

reservedIl progetto di tesi magistrale ha ruotato attorno alla valutazione di una nuova strategia combinatoria contro il mesotelioma pleurico maligno e ha previsto l'uso di immunoterapie.
BETTINSOLI, ELENA
core  

Modern management of malignant pleural mesothelioma

, 2016
Shivani C Patel,1 Jonathan E Dowell1,2 1Division of Hematology and Oncology, University of Texas Southwestern, 2Section of Hematology and Oncology, Veterans Affairs North Texas Healthcare System, Dallas, TX, USA Abstract: Malignant pleural mesothelioma (
Dowell JE, Patel SC
core  

Pleural sarcomatoid mesothelioma: a rare type of malignant mesothelioma

, 2017
Malignant pleural mesothelioma is the most common primary tumor of the pleura and carries a poor prognosis. CT remains the method of choice to diagnosis, staging and follow-up this pathology although MR imaging and PET/CT with fluorodeoxyglucose have ...
Leitão, Patrícia, Araújo, André, Gonçalves, José, Araújo, Bruno   +3 more
core   +1 more source